Pilot study of aprepitant effect on aldosterone secretion in diabetic patient (diabetes mellitus) with hypertension associated with low renin

Trial Profile

Pilot study of aprepitant effect on aldosterone secretion in diabetic patient (diabetes mellitus) with hypertension associated with low renin

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Aprepitant (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms APHOS-02
  • Most Recent Events

    • 28 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Jul 2019.
    • 28 Jun 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Jul 2019.
    • 28 Jun 2017 Planned initiation date changed from 1 Sep 2016 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top